CVE intelligence and bounded remediation
CVE-2020-10627 — Insulet Omnipod Insulin Management System Firmware security vulnerability
Insulet Omnipod Insulin Management System insulin pump product ID 19191 and 40160 is designed to communicate using a wireless RF with an Insulet manufactured Personal Diabetes Manager device. This wireless RF communication protocol does not properly implement authentication or authorization. An attacker with access to one of the affected insulin pump models may be able to modify and/or intercept data. This vulnerability could also allow attackers to change pump settings and control insulin delivery.
- Severity
- High
- CVSS
- 8.1 (3.1)
- Published
- 2021-12-01
- CISA KEV
- Not currently listed
- Ecosystem
- operating-system
- Weaknesses
- CWE-284
Affected products
- insulet / omnipod_insulin_management_system_firmware
Matched remediation archetype
Authorization bypass, IDOR, and cross-tenant access
This catalog composition supplies bounded fallback guidance. Explicitly reviewed curated workflows load with the complete record below.
Check exposure
- Map object and action authorization checks across API, UI, batch, import/export, and background-job paths.
- Identify tenant, ownership, role, and policy boundaries for affected resources and administrative operations.
- Use synthetic fixtures to compare intended access matrices without accessing another user's real data.
Remediate safely
- Enforce server-side authorization at each resource access and state transition using the authenticated principal and trusted tenant context.
- Scope data queries by tenant and ownership; treat client-supplied identifiers, roles, and policy claims as untrusted.
- Add deny-by-default policy tests for horizontal and vertical access across every affected transport.
Authoritative sources
Complete CVE record and remediation plan
The detailed catalog view below loads this exact record, its source evidence, and the full seven-phase agentic change plan.